Kailera Therapeutics Inc (KLRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Operating Expenses | 84,660 | 0 | 20,458 |
| Operating Income | -84,660 | N/A | -20,458 |
| Other Income | 5,795 | 0 | 2,475 |
| Pre-tax Income | -78,865 | 0 | -17,983 |
| Net Income Continuous | -78,865 | N/A | -17,983 |
| Net Income | $-78,865 | $N/A | $-17,983 |
| EPS Basic Total Ops | -3,650.00 | N/A | -17,983.00 |
| EPS Basic Continuous Ops | -3,649.97 | N/A | -17,983,000.00 |
| EPS Diluted Total Ops | -3,650.00 | N/A | -17,983.00 |
| EPS Diluted Continuous Ops | -3,649.97 | N/A | -17,983,000.00 |
| EBITDA(a) | $-84,559 | $N/A | $-20,395 |